IGC Pharma (IGS1) Q2 2026 Earnings Report
DE:IGS1 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -EUR 0.02
DE:IGS1 Q2 2026 Revenue Results
- Actual Revenue
- EUR 171.02K
- Expected Revenue
- EUR 342.94K
- Beat/Miss
- Missed by -EUR 171.92K
- YoY Revenue Growth
- -53.64%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/17/2025
- Time
- Before Open
- Conference Call
- Monday, November 17, 2025
DE:IGS1 Upcoming Earnings
IGC Pharma's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:IGS1 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IGS1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2027 (Q2) | -0.02- | -0.02 | ― | ― |
| Jun 15, 2026 | 2026 (Q4) | ―-0.02 | -0.02 | 0.00% (+0.00) | |
| Mar 19, 2026 | 2026 (Q3) | -0.02-0.01 | -0.02 | 50.00% (+0.01) | |
| Nov 17, 2025 | 2026 (Q2) | -0.02-0.02 | -0.02 | 0.00% (+0.00) | |
| Aug 19, 2025 | 2026 (Q1) | ―- | -0.03 | ― | |
| Jun 30, 2025 | 2025 (Q4) | -0.02-0.02 | -0.03 | 33.33% (+0.01) | |
| Feb 18, 2025 | 2025 (Q3) | -0.03-0.02 | -0.08 | 77.78% (+0.06) | |
| Nov 14, 2024 | 2025 (Q2) | -0.03-0.02 | -0.04 | 60.00% (+0.03) | |
| Aug 09, 2024 | 2025 (Q1) | -0.03-0.03 | -0.03 | 23.08% (+0.01) | |
| Jun 24, 2024 | 2024 (Q4) | -0.04-0.03 | -0.07 | 53.95% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
